Gotham Asset Management LLC Has $3.32 Million Stake in Maximus, Inc. (NYSE:MMS)

Gotham Asset Management LLC grew its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 72.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,401 shares of the health services provider's stock after acquiring an additional 18,608 shares during the period. Gotham Asset Management LLC owned 0.08% of Maximus worth $3,315,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. UMB Bank n.a. lifted its position in Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after acquiring an additional 158 shares during the last quarter. Eastern Bank acquired a new stake in shares of Maximus in the fourth quarter valued at approximately $29,000. V Square Quantitative Management LLC grew its position in Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after buying an additional 180 shares in the last quarter. R Squared Ltd bought a new position in Maximus during the 4th quarter worth $54,000. Finally, IFP Advisors Inc increased its stake in Maximus by 62.4% during the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after acquiring an additional 302 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Maximus Price Performance

Maximus stock traded down $0.24 during mid-day trading on Friday, reaching $75.09. 447,250 shares of the company were exchanged, compared to its average volume of 562,348. The company has a fifty day simple moving average of $68.71 and a 200-day simple moving average of $72.65. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The firm has a market cap of $4.23 billion, a PE ratio of 16.15 and a beta of 0.61.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same quarter last year, the company earned $1.57 EPS. The company's revenue was up 1.0% on a year-over-year basis. As a group, equities research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.60%. Maximus's payout ratio is 23.86%.

Insider Activity

In other news, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. This trade represents a 85.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research note on Thursday.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.